Prosecution Insights
Prosecution Insights
Tech Center 1600 • Art Units: 1626
This examiner grants 75% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18010642 | COMPOUNDS AND METHODS FOR BLOCKING APOPTOSIS AND INDUCING AUTOPHAGY | Non-Final OA | President and Fellows of Harvard College |
| 17642662 | CYCLOOXYGENASE-2 INHIBITORS AND USES THEREOF | Non-Final OA | President and Fellows of Harvard College |
| 17908819 | PROCESS FOR MANUFACTURE OF A COMPLEXING AGENT | Final Rejection | BASF SE |
| 17369032 | UBE2K MODULATORS AND METHODS FOR THEIR USE | Final Rejection | BPGbio, Inc. |
| 17802823 | INTERCELLULAR AND INTRACELLULAR PROXIMITY-BASED LABELING COMPOSITIONS AND SYSTEMS | Non-Final OA | The Trustees of Princeton University |
| 13895089 | NOVEL BICYCLIC HETEROCYCLIC COMPOUND | Final Rejection | SUMITOMO PHARMA CO., LTD. |
| 17927762 | BENZYLAMINE DERIVATIVES AS DDRS INHIBITORS | Final Rejection | CHIESI FARMACEUTICI S.P.A. |
| 17964423 | 1H-PYRROLO[2,3-B]PYRIDINES AND PREPARATION AND USES THEREOF | Non-Final OA | BioSplice Therapeutics, Inc. |
| 18246586 | ALPHA PROTEIN KINASE 1 INHIBITORS AND METHODS OF USE | Final Rejection | Shanghai Yao Yuan Biotechnology Co., Ltd. |
| 17773216 | COMBINATION OF A CXCR7 ANTAGONIST WITH AN S1P1 RECEPTOR MODULATOR | Non-Final OA | Idorsia Pharmaceuticals Ltd. |
| 18026054 | SMALL MOLECULE INHIBITORS OF LEMUR TYROSINE KINASE 3 | Non-Final OA | The University of Sussex |
| 18274867 | NOVEL BENZOTRIAZOLE DERIVATIVE HAVING INHIBITORY ACTIVITY AGAINST ECTONUCLEOTIDE PYROPHOSPHATASE-PHOSPHODIESTERASE, AND USE THEREOF | Non-Final OA | TXINNO BIOSCIENCE INC. |
| 18129310 | HETEROCYCLIC COMPOUND, ORGANIC LIGHT EMITTING DEVICE COMPRISING SAME AND COMPOSITION FOR ORGANIC LAYER OF ORGANIC LIGHT EMITTING DEVICE | Non-Final OA | LT MATERIALS CO., LTD. |
| 17998234 | COMPOUNDS AS BCL-2 INHIBITORS | Non-Final OA | Fochon Biosciences, Ltd. |
| 17972008 | PROCESS FOR THE PREPARATION OF SODIUM 4-(2-((1E,3E,5E,7Z)-7-(1,1-DIMETHYL-3-(4-SULFONATOBUTYL)-1H-BENZO[e]INDOL-2(3H)-YLIDENE) HEPTA-1,3,5-TRIENYL)-1,1-DIMETHYL-1H-BENZO[e]INDOLIUM-3-YL) BUTANE-1-SULFONATE (INDOCYANINE GREEN) | Final Rejection | BIOPHORE INDIA PHARMACEUTICALS PVT. LTD. |
| 17768725 | ERGOLINE-LIKE COMPOUNDS FOR PROMOTING NEURAL PLASTICITY | Final Rejection | Delix Therapeutics, Inc. |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy